Predicting breast cancer treatment success with imaging
Part of Cancer, Skin clinical trials.
This trial uses your MRI, ultrasound, and mammogram images, along with biopsy results, to predict how well neoadjuvant therapy (treatment before surgery) will work for your breast cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with invasive breast cancer through a biopsy.
- You are scheduled to receive a full course of neoadjuvant therapy (treatment before surgery).
- You have complete baseline imaging (MRI, ultrasound, or mammogram) available.
- You do not have a history of breast cancer on the same side or chest radiation.
- Your cancer has not spread to distant parts of the body (Stage IV).
- Your imaging and medical records are of good quality.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This research uses artificial intelligence to improve how doctors diagnose breast conditions from 3D mammogram images (called digital breast tomosynthesis). Researchers are testing whether AI can help detect breast cancer more accurately and predict treatment outcomes.
This trial uses an artificial intelligence model to predict how well breast cancer responds to neoadjuvant therapy (treatment before surgery). It aims to improve treatment planning by analyzing MRI scans taken before and after therapy.
This trial uses a special PET/MRI scan combined with artificial intelligence to see if it can predict whether HER2-positive breast cancer will completely disappear after treatment given before surgery. The goal is to learn who might avoid surgery or get a more tailored approach.
This study looks at breast cancer images to see whether computer-extracted patterns (“radiomics”) can help improve understanding of the disease. You may be included if your breast cancer diagnosis is confirmed and your medical records are complete.
This study uses existing breast ultrasound images to test how well artificial intelligence (AI) can interpret them. It may help improve future breast cancer detection tools.
This trial tests if a special imaging analysis can predict where your cancer might spread. It's for people with advanced lung, colorectal, or breast cancer who are starting or continuing treatment.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.